Animi-3

Omega-3, Folic Acid, Vitamin B6 and B12

Studies published in peer-reviewed journals have reported that patients with cardiovascular disease, diabetes, rheumatoid arthritis, and depression may be deficient in vital nutrients:

• Omega-3
• Folic acid
• Vitamin B6 and B12

Addressing these deficiencies may reduce cardiovascular risk.*

Animi-3 is a prescription-only product with specially formulated and highly refined omega-3 fatty acids. Animi-3 also contains phytosterols and the B vitamins: folic acid, B6, and B12.

Animi-3 provides assurance of dosing control for these vital nutrients.

The DHA & B Vitamins Center

You can learn more about omega-3 fatty acids and essential B vitamins by visiting a new Web site, www.dhaandbvitamins.org, which was created via an unrestricted educational grant to help educate health-care professionals and other online visitors on the importance of omega-3 fatty acids (DHA and EPA) and B vitamins in dietary health.

The DHA & B Vitamins Center gives you access to resources developed by specialists at Weill Cornell Medical College, New York Presbyterian Hospital, as well as other major academic medical centers. The information on omega-3s and B vitamins was developed through a collaborative framework based on the expertise and published work of physicians, nutritionists, and research scientists from our institution and other medical research institutions worldwide.

Pharmacy Stocking

Animi-3 is available at all drug wholesalers and is available by prescription at local pharmacies. Animi-3 is also available at the drugstore.com™ Web store for immediate prescription filling.

Demand for this new product is increasing as many physicians are already prescribing it for their patients. For stocking assistance, please contact PBM Pharmaceuticals, Inc., at the following number:

1-800-485-9828

* FDA “Qualified Health Claims” B vitamins & Vascular Disease. As part of a well-balanced diet that is low in saturated fat and cholesterol, Folic Acid, Vitamin B6 and Vitamin B12 may reduce the risk of vascular disease. FDA evaluated the above claim and found that, while it is known that diets low in saturated fat and cholesterol reduce the risk of heart disease and other vascular diseases, the evidence in support of the above claim is inconclusive. Docket No. 99P-3029.

FDA “Qualified Health Claims” Omega-3 Fatty Acids & Coronary Heart Disease. Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the above claim and determined that, although there is scientific evidence supporting the claim, the evidence is not conclusive. Docket No. 9IN-0103.